Reiley Pharmaceuticals, Inc. — Form D/A

Reiley Pharmaceuticals, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2022-10-19. The offering totals $447K, of which $100K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2022-10-19
• Form: D/A
• Accession: 0001616308-22-000004
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $447K
• Amount sold: $100K
• Remaining: $347K
• Minimum investment: $10K
• Investors: 2
• Date of first sale: 2022-10-12
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-462121

Issuer

• Name: Reiley Pharmaceuticals, Inc.
• CIK: 0001616308
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 3749 BUCHANAN STREET, SAN FRANCISCO, CA, 94147
• Phone: 650 269-8044

Officers, directors & promoters (9)

Other filings by this issuer (7)

More

• CIK 1616308 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search